NBRP’s mRNA facility accelerates progress in mRNA-related clinical trials

撰文GlobalBio & Investment
日期2023-12-31
EnglishFrenchGermanItalianPortugueseRussianSpanish
NBRP’s mRNA facility accelerates progress in mRNA-related clinical trials
The therapeutic use of #mRNA has fueled great hope to fight a broad range of incurable diseases. Not just against COVID-19 but also crafting personalized cancer vaccines! Exciting news awaits as we hope for NBRP’s mRNA facilities to accelerate mRNA-related clinical trial progress.

Read more: https://lnkd.in/dveyd_2q

#mRNAtherapy #CancerVaccines #NBRP #BiohubTaiwan

GlobalBio & Investment

Go Global and Beyond:
A Premier Biomedical Media in Taiwan
下一篇
Introducing the CellTech Innovation Accelerator, where innovation begins from "zero to one"

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務